These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 28091920)

  • 1. Comparative Study of Antitumor Efficiency of Intraperitoneal and Intravenous Cytostatics in Experimental Rats with Disseminated Ovarian Cancer.
    Bespalov VG; Vyshinskaya EA; Vasil'eva IN; Semenov AL; Maidin MA; Barakova NV; Stukov AN
    Bull Exp Biol Med; 2017 Jan; 162(3):383-386. PubMed ID: 28091920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antitumor activity of dioxadet compared with cisplatin on ascitic ovarian tumor in rats].
    Bespalov VG; Beliaeva OA; Panchenko AV; Stukov AN; Gershanovich ML; Murazov IaG; Kon'kov SA; Kil'maeva NE; Krylova IM; Mironiuk TA; Latipova DKh
    Vopr Onkol; 2011; 57(6):771-4. PubMed ID: 22416396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraperitoneal chemotherapy--a method of improving treatment effectiveness in ovarian cancer].
    Bespalov VG; Vyshinskaya EA; Vasilieva IN; Maidin MA; Semenov AL; Stukov AN; Kireeva GS; Belyaeva OA; Kopteva OS; Krasilnikova LA; Alexandrov VA; Belyaev AM
    Vopr Onkol; 2015; 61(4):634-41. PubMed ID: 26571836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor effect of dioxadet in intraperitoneal chemoperfusion treatment for advanced ovarian cancer in experimental setting].
    Bespalov VG; Beliaeva OA; Kireeva GS; Senchik KIu; Stukov AN; Aristova VA; Vyshinskaia EA; Kon'kov SA; Krylova IA; Semënov AL; Maĭdin MA; Aleksandrov VA; Beliaev AM
    Vopr Onkol; 2014; 60(2):72-9. PubMed ID: 24919266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative efficacy evaluation of catheter intraperitoneal chemotherapy, normothermic and hyperthermic chemoperfusion in a rat model of ascitic ovarian cancer.
    Bespalov VG; Alvovsky IK; Tochilnikov GV; Stukov AN; Vyshinskaya EA; Semenov AL; Vasilyeva IN; Belyaeva OA; Kireeva GS; Senchik KY; Zhilinskaya NT; Von JD; Krasilnikova LA; Alexandrov VA; Khromov-Borisov NN; Baranenko DA; Belyaev AM
    Int J Hyperthermia; 2018 Aug; 34(5):545-550. PubMed ID: 28893108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of antitumor activity of cisplatin using agonist of gonadotropin-realising hormone and inhibitor of aromatase on the model of ascites ovarian tumor.
    Tkalia IG; Vorobyova LI; Grabovoy AN; Svintsitsky VS; Tarasova TO; Lukyanova NY; Todor IN; Chekhun VF
    Exp Oncol; 2014 Sep; 36(3):184-90. PubMed ID: 25265352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraoperative intraperitoneal chemoperfusion treatment with cisplatin and dioxadet on a model of peritoneal carcinomatosis in ovarian cancer: safety and efficacy evaluation].
    Bespalov VG; Kireeva GS; Belyaeva OA; Senchik KY; Stukov AN; Gafton GI; Soloviev LA; Vasilchenko MV; Guseinov KD; Alexeev VV; Belyaev AM
    Vopr Onkol; 2015; 61(4):647-52. PubMed ID: 26571838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potentiation of the antitumor activity of dioxadet by antiestrogen para-aminobenzhydrazide in a model of ovarian ascites tumor].
    Tret'iakov AV; Kraĭz BO
    Vopr Onkol; 1983; 29(12):66-8. PubMed ID: 6666098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor efficacy of cisplatin in combination with triptorelin and exemestane therapy for an ovarian cancer ascites model in Wistar rats.
    Tkalia IG; Vorobyova LI; Grabovoy AN; Svintsitsky VS; Tarasova TO
    Exp Oncol; 2015 Mar; 37(1):30-5. PubMed ID: 25804228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both heat and new chemotherapeutic drug dioxadet in hyperthermic intraperitoneal chemoperfusion improved survival in rat ovarian cancer model.
    Bespalov VG; Kireeva GS; Belyaeva OA; Kalinin OE; Senchik KY; Stukov AN; Gafton GI; Guseynov KD; Belyaev AM
    J Surg Oncol; 2016 Mar; 113(4):438-42. PubMed ID: 26710749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].
    Beliaeva OA; Bespalov VG; Senchik KIu; Kireeva GS; Stukov AN; Aristova VA; Ivantsov AO; Vyshinskaia EA; Maĭdin MA; Semënov AL; Aleksandrov VA; Beliaev AM
    Vopr Onkol; 2014; 60(1):71-9. PubMed ID: 24772620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a murine model for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer.
    Mannel RS; Stratton JA; Rettenmaier MA; Liao SY; DiSaia PJ
    Gynecol Oncol; 1988 Sep; 31(1):50-5. PubMed ID: 3410355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I trial of intravenous melphalan, paclitaxel, and cisplatin plus granulocyte-colony stimulating factor in patients with suboptimal advanced epithelial ovarian carcinoma or peritoneal carcinoma.
    Gershenson DM; Morris M; Burke TW; Levenback C; Wolf J; Lee JJ; Thall PF; Atkinson EN; Silva EG; Wharton JT
    Cancer; 1999 Dec; 86(11):2291-300. PubMed ID: 10590370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm.
    Terauchi F; Moritake T; Yamamoto Y; Ogura H
    Int J Clin Oncol; 2002 Dec; 7(6):356-60. PubMed ID: 12494251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental study of antitumour activity and effects on leukocyte count of intraperitoneal administration and hyperthermic intraperitoneal chemoperfusion (HIPEC) with dioxadet in a rat model of ovarian cancer.
    Bespalov VG; Kireeva GS; Belyaeva OA; Senchik KY; Stukov AN; Maydin MA; Semenov AL; Gafton GI; Guseynov KD; Belyaev AM
    J Chemother; 2016 Jun; 28(3):203-9. PubMed ID: 26027427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of 7-N-(2-((2-(gamma-L-glutamylamino) ethyl) dithio) ethyl) mitomycin C (KW2149) against human tumor xenografts serially transplanted into nude mice.
    Kubota T; Inada T; Inoue S; Kuzuoka M; Arisawa Y; Suto A; Kodaira S; Ishibiki K; Abe O
    Jpn J Clin Oncol; 1989 Sep; 19(3):216-21. PubMed ID: 2554025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexamethylmelamine and melphalan as salvage therapy in advanced ovarian carcinoma.
    Tempero MA; Kessinger A
    J Surg Oncol; 1982 Nov; 21(3):159-61. PubMed ID: 6813600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model.
    Duiker EW; de Vries EG; Mahalingam D; Meersma GJ; Boersma-van Ek W; Hollema H; Lub-de Hooge MN; van Dam GM; Cool RH; Quax WJ; Samali A; van der Zee AG; de Jong S
    Clin Cancer Res; 2009 Mar; 15(6):2048-57. PubMed ID: 19276284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.